{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T05:38:17Z","timestamp":1707889097875},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"52","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1097\/md.0000000000009055","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T15:54:31Z","timestamp":1514390071000},"page":"e9055","source":"Crossref","is-referenced-by-count":1,"title":["Diagnosis and treatment of neoplastic post-transplant lymphoproliferative disorder following hematopoietic stem cell transplant in \u03b2-thalassemia"],"prefix":"10.1097","volume":"96","author":[{"given":"Xiaohong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenge","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210226","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/MOP.0000000000000445","article-title":"Management of post-transplant lymphoproliferative disorders","volume":"29","author":"Llaurador","year":"2017","journal-title":"Curr Opin Pediatr"},{"key":"R2-6-20210226","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1399-3046.2012.01656.x","article-title":"Emerging therapeutic strategies for Epstein\u2013Barr virus+ post-transplant lymphoproliferative disorder","volume":"16","author":"Olivia","year":"2012","journal-title":"Pediatr Transplant"},{"key":"R3-6-20210226","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1111\/j.1600-6143.2012.04206.x","article-title":"Low-dose chemotherapy and rituximab for posttransplant lymphoproliferative disease (PTLD): a Children's Oncology Group Report","volume":"12","author":"Gross","year":"2012","journal-title":"Am J Transplant"},{"key":"R4-6-20210226","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3346\/jkms.2010.25.4.523","article-title":"Clinical characteristics of monomorphic post-transplant lymphoproliferative disorders","volume":"25","author":"Choi","year":"2010","journal-title":"J Korean Med Sci"},{"key":"R5-6-20210226","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.bbmt.2010.08.007","article-title":"Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients","volume":"17","author":"Reddy","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"R6-6-20210226","doi-asserted-by":"crossref","first-page":"814973","DOI":"10.1155\/2013\/814973","article-title":"Posttransplant lymphoproliferative disease after pediatric solid organ transplantation","volume":"2013","author":"Mynarek","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"R7-6-20210226","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5045\/br.2013.48.2.149","article-title":"Hematological malignancies complicating \u03b2-thalassemia syndromes: a single center experience","volume":"48","author":"Alavi","year":"2013","journal-title":"Blood Res"},{"key":"R8-6-20210226","first-page":"46","article-title":"Atypical lymphoproliferative diseases.","volume":"133-","author":"Greiner","year":"2000","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R9-6-20210226","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"R10-6-20210226","doi-asserted-by":"crossref","first-page":"505","DOI":"10.5500\/wjt.v6.i3.505","article-title":"Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders","volume":"6","author":"Morscio","year":"2016","journal-title":"World J Transplant"},{"key":"R11-6-20210226","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4103\/1319-2442.152398","article-title":"A meta-analysis of potential relationship between Epstein-Barr-Encoded-RNA (EBER) and onset time of post-transplant lymphoproliferative disorders","volume":"26","author":"Khedmat","year":"2015","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R12-6-20210226","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1399-3062.2009.00411.x","article-title":"Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases","volume":"11","author":"Styczynski","year":"2009","journal-title":"Transpl Infect Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000009055","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:45:55Z","timestamp":1620960355000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201712290-00006"}},"subtitle":["A pediatric case report"],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":12,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000009055","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}